SGLT2 Inhibitors in the Modern Cardiology Era: Mechanisms, Outcomes, and Clinical Applications.

Neshat N, Daneii P, Neshat S, Mojahedi A, Frishman WH, Aronow WS

Open source

DOI
10.1097/crd.0000000000001420
Published
2026 Aug 3
Container
Cardiology in review
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/crd.0000000000001420,
  title = {SGLT2 Inhibitors in the Modern Cardiology Era: Mechanisms, Outcomes, and Clinical Applications.},
  author = {Neshat N and Daneii P and Neshat S and Mojahedi A and Frishman WH and Aronow WS},
  year = {2026},
  journal = {Cardiology in review},
  doi = {10.1097/crd.0000000000001420},
  url = {https://doi.org/10.1097/crd.0000000000001420}
}

RIS

TY  - JOUR
TI  - SGLT2 Inhibitors in the Modern Cardiology Era: Mechanisms, Outcomes, and Clinical Applications.
AU  - Neshat N
AU  - Daneii P
AU  - Neshat S
AU  - Mojahedi A
AU  - Frishman WH
AU  - Aronow WS
PY  - 2026
JO  - Cardiology in review
DO  - 10.1097/crd.0000000000001420
UR  - https://doi.org/10.1097/crd.0000000000001420
ER  - 

APA

N, N., P, D., S, N., A, M., WH, F., & WS, A. (2026). SGLT2 Inhibitors in the Modern Cardiology Era: Mechanisms, Outcomes, and Clinical Applications.. Cardiology in review. https://doi.org/10.1097/crd.0000000000001420

Source records